J.P. Morgan Private Wealth Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $208K | Sell |
10,000
-1,058
| -10% | -$22K | ﹤0.01% | 1620 |
|
|
2023
Q2 | $265K | Sell |
11,058
-3,445
| -24% | -$82.5K | ﹤0.01% | 1287 |
|
|
2023
Q1 | $273K | Sell |
14,503
-582
| -4% | -$11K | ﹤0.01% | 1720 |
|
|
2022
Q4 | $240K | Buy |
+15,085
| New | +$240K | ﹤0.01% | 1742 |
|
|
2022
Q1 | – | Sell |
-15,628
| Closed | -$365K | – | 1996 |
|
|
2021
Q4 | $365K | Sell |
15,628
-1,115
| -7% | -$26K | ﹤0.01% | 1665 |
|
|
2021
Q3 | $278K | Sell |
16,743
-61
| -0.4% | -$1.01K | ﹤0.01% | 1722 |
|
|
2021
Q2 | $410K | Sell |
16,804
-1,641
| -9% | -$40K | ﹤0.01% | 1554 |
|
|
2021
Q1 | $476K | Buy |
18,445
+8,655
| +88% | +$223K | ﹤0.01% | 1330 |
|
|
2020
Q4 | $523K | Buy |
9,790
+228
| +2% | +$12.2K | ﹤0.01% | 1274 |
|
|
2020
Q3 | $394K | Buy |
9,562
+1,126
| +13% | +$46.4K | ﹤0.01% | 1246 |
|
|
2020
Q2 | $409K | Buy |
8,436
+39
| +0.5% | +$1.89K | ﹤0.01% | 1188 |
|
|
2020
Q1 | $355K | Buy |
+8,397
| New | +$355K | ﹤0.01% | 1067 |
|
|
2017
Q2 | – | Sell |
-7,703
| Closed | -$265K | – | 1232 |
|
|
2017
Q1 | $265K | Buy |
+7,703
| New | +$265K | ﹤0.01% | 1123 |
|
|
2016
Q4 | – | Sell |
-9,901
| Closed | -$315K | – | 1242 |
|
|
2016
Q3 | $315K | Buy |
9,901
+2,370
| +31% | +$75.4K | ﹤0.01% | 971 |
|
|
2016
Q2 | $244K | Sell |
7,531
-837
| -10% | -$27.1K | ﹤0.01% | 1068 |
|
|
2016
Q1 | $235K | Buy |
+8,368
| New | +$235K | ﹤0.01% | 1028 |
|